Sign up to save your podcasts
Or
Share Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
Alexander Menzies, a Medical Oncologist and Associate Professor of Melanoma Medical Oncology at Melanoma Institute Australia (MIA), The University of Sydney, and Royal North Shore and Mater Hospitals discusses appropriate biomarkers and treatments for Stage IV Melanoma.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Alexander Menzies, a Medical Oncologist and Associate Professor of Melanoma Medical Oncology at Melanoma Institute Australia (MIA), The University of Sydney, and Royal North Shore and Mater Hospitals discusses appropriate biomarkers and treatments for Stage IV Melanoma.
More shows like ASCO Education
View all
Exchanges
979 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JCO Oncology Practice Podcast
17 Listeners
ASCO Daily News
57 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
284 Listeners
The Curbsiders Internal Medicine Podcast
3,338 Listeners
WSJ Minute Briefing
677 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
ASCO Guidelines
44 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
NEJM AI Grand Rounds
58 Listeners
Two Onc Docs
185 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners